Fierce Pharma

Spruce hooks a commercial chief to prep for rare disease launch

Spruce Biosciences has named Dale Hooks chief commercial officer, securing a leader with experience launching 21 products as the company heads toward a filing for its first FDA approval.
Yahoo Finance

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

Biologics License Application (BLA) Submission to U.S. FDA for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Anticipated in 1H 2026 Spruce to Host Conference Call Today at 8:30 a.m. ET "This ...
FierceBiotech

Spruce halves head count, narrowing focus to get ex-BioMarin drug to FDA

Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former BioMarin rare disease candidate that it plans to file for a speedy approval ...
Yahoo Finance

H&R Block Customers Can Now Open a Spruce Account When Working with a Tax Pro

KANSAS CITY, Mo., March 14, 2023 (GLOBE NEWSWIRE) -- For the more than two-thirds 2 of Americans who get money back at tax time, a refund can be a great opportunity to get ahead financially. Each year ...